What is NDC 69945-177?

69945-177 is the product NDC for Bexlutry (lutetium oxodotreotide lu-177), Lutetium oxodotreotide lu-177 10 mCi/mL injection, listed with the FDA by Curium US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Bexlutry (Lutetium oxodotreotide lu-177).

Curium US LLC, NDC labeler code 69945. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Bexlutry?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Bexlutry NDC 69945-177 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)69945-177Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69945-0177Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69945-177-01	6994501770169945017701	20 mL in 1 VIAL, SINGLE-DOSE (69945-177-01)Marketed from Sep 14, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bexlutry
Generic name (nonproprietary): lutetium oxodotreotide lu-177
Active ingredients: Lutetium oxodotreotide lu-177 — 10 mCi/mL
Dosage form: Injection
Route: Intravenous
Labeler: Curium US LLCNDC labeler code 69945
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 218525
Marketing start: Sep 14, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 69945-177_5b8746b6-9986-11cc-e063-6394a90af38bSPL ID 5b8746b6-9986-11cc-e063-6394a90af38b

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N469945017701 followed by a unit qualifier and the quantity

Package 69945-0177-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 69945-177

What is NDC 69945-177?: 69945-177 is the product NDC for Bexlutry (lutetium oxodotreotide lu-177), Lutetium oxodotreotide lu-177 10 mCi/mL injection, listed with the FDA by Curium US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Bexlutry (Lutetium oxodotreotide lu-177).
What is the active ingredient?: Lutetium oxodotreotide lu-177.
Who is the labeler?: Curium US LLC, NDC labeler code 69945. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Bexlutry?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Bexlutry (Lutetium oxodotreotide lu-177) NDC 69945-177